Blockers of Wnt3a, Wnt10a, or beta-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hee Kee | - |
dc.contributor.author | Bae, Jingi | - |
dc.contributor.author | Lee, Sung Ho | - |
dc.contributor.author | Hwang, Seon-Hee | - |
dc.contributor.author | Kim, Min-Sik | - |
dc.contributor.author | Kim, Moon Jong | - |
dc.contributor.author | Jun, Sohee | - |
dc.contributor.author | Cervantes, Chris L. | - |
dc.contributor.author | Jung, Youn-Sang | - |
dc.contributor.author | Back, Seunghoon | - |
dc.contributor.author | Lee, Hangyeore | - |
dc.contributor.author | Lee, Seung-Eun | - |
dc.contributor.author | Dougherty, Patrick M. | - |
dc.contributor.author | Lee, Sang-Won | - |
dc.contributor.author | Park, Jae-Il | - |
dc.contributor.author | Abdi, Salahadin | - |
dc.date.accessioned | 2022-06-20T07:40:43Z | - |
dc.date.available | 2022-06-20T07:40:43Z | - |
dc.date.created | 2022-06-20 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 1933-7213 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/84718 | - |
dc.description.abstract | Although chemotherapy is a key cancer treatment, many chemotherapeutic drugs produce chronic neuropathic pain, called chemotherapy-induced neuropathic pain (CINP), which is a dose-limiting adverse effect. To date, there is no medicine that prevents CINP in cancer patients and survivors. We determined whether blockers of the canonical Wnt signaling pathway prevent CINP. Neuropathic pain was induced by intraperitoneal injection of paclitaxel (PAC) on four alternate days in male Sprague-Dawley rats or male Axin2-LacZ knock-in mice. XAV-939, LGK-974, and iCRT14, Wnt/beta-catenin blockers, were administered intraperitoneally as a single or multiple doses before or after injury. Mechanical allodynia, phosphoproteome profiling, Wnt ligands, and inflammatory mediators were measured by von Frey filament, phosphoproteomics, reverse transcription-polymerase chain reaction, and Western blot analysis. Localization of beta-catenin was determined by immunohistochemical analysis in the dorsal root ganglia (DRGs) in rats and human. Our phosphoproteome profiling of CINP rats revealed significant phosphorylation changes in Wnt signaling components. Importantly, repeated systemic injections of XAV-939 or LGK-974 prevented the development of CINP in rats. In addition, XAV-939, LGK-974, and iCRT14 ameliorated CINP. PAC increased Wnt3a and Wnt10a, activated beta-catenin in DRG, and increased monocyte chemoattractant protein-1 and interleukin-1 beta in DRG. PAC also upregulated rAxin2 in mice. Furthermore, beta-catenin was expressed in neurons, including calcitonin gene-related protein-expressing neurons and satellite cells in rat and human DRG. In conclusion, chemotherapy increases Wnt3a, Wnt10a, and beta-catenin in DRG and their pharmacological blockers prevent and ameliorate CINP, suggesting a target for the prevention and treatment of CINP. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.relation.isPartOf | NEUROTHERAPEUTICS | - |
dc.title | Blockers of Wnt3a, Wnt10a, or beta-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000585714300002 | - |
dc.identifier.doi | 10.1007/s13311-020-00956-w | - |
dc.identifier.bibliographicCitation | NEUROTHERAPEUTICS, v.18, no.1, pp.601 - 614 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85094630832 | - |
dc.citation.endPage | 614 | - |
dc.citation.startPage | 601 | - |
dc.citation.title | NEUROTHERAPEUTICS | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Kim, Moon Jong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Chemotherapy-induced neuropathic pain | - |
dc.subject.keywordAuthor | Wnt ligand | - |
dc.subject.keywordAuthor | Wnt3a | - |
dc.subject.keywordAuthor | Wnt10a | - |
dc.subject.keywordAuthor | beta-catenin | - |
dc.subject.keywordAuthor | prevention | - |
dc.subject.keywordPlus | IMMUNOREACTIVE NERVE-FIBERS | - |
dc.subject.keywordPlus | WNT/BETA-CATENIN | - |
dc.subject.keywordPlus | SPINAL-CORD | - |
dc.subject.keywordPlus | PEPTIDE CGRP | - |
dc.subject.keywordPlus | PERIPHERAL-NERVE | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.